Skip to main content
. 2021 Dec 13;61(8):3246–3256. doi: 10.1093/rheumatology/keab861

Fig. 3.


Fig. 3

Cumulative probability plots of mean change in mTSS in the (A) LE and (B) as-observed analyses

The 1-year analysis. In SELECT-COMPARE, at week 26 (6-month visit), patients receiving placebo were switched to upadacitinib. eow: every other week.